~$2–2.5B
Pharmaceutical market value 2026
~37M
Population
~70%
Local production share (volume)
12–24 mo
DMP registration timeline
Morocco Pharmaceutical Market Overview
Morocco is North Africa's second-largest pharmaceutical market after Egypt, valued at approximately US$2–2.5 billion in 2026 for a population of 37 million. Local manufacturing covers roughly 70% of volume through some 50 licensed plants concentrated around Casablanca, with the sector ranked among Africa's most developed by WHO maturity criteria.
The Direction du Médicament et de la Pharmacie (DMP) within the Ministry of Health regulates registration, pricing, and pharmacovigilance. Morocco applies government-decreed price ceilings referenced to a six-country basket, and the AMO (Assurance Maladie Obligatoire) generalisation programme is progressively extending insurance coverage to the whole population — the single biggest demand-side driver.
Sothema, Cooper Pharma, Laprophan, Pharma 5, and Galenica lead local manufacturing; several also export across Francophone West Africa. Multinationals operate through local plants (Sanofi's Maphar heritage) or scientific offices in Casablanca.
Top Pharmaceutical Companies in Morocco
The following table lists the major pharmaceutical companies operating in Morocco — including local manufacturers, multinational offices, regional players, and leading distributors.
| Company | HQ |
|---|---|
| Sothema | Morocco |
| Cooper Pharma | Morocco |
| Laprophan | Morocco |
| Pharma 5 | Morocco |
| Galenica | Morocco |
| Afric-Phar | Morocco |
| Zenith Pharma | Morocco |
| Sanofi Maroc (Maphar) | France / Morocco |
| Pfizer | USA |
| Novartis | Switzerland |
| Roche | Switzerland |
| GSK | UK |
| AstraZeneca | UK / Sweden |
| MSD | USA |
| Hikma Pharmaceuticals | Jordan / UK |
| Julphar | UAE |
| Maphar Distribution | Morocco |
| Sophadial / regional wholesalers | Morocco |
Planning research in Morocco?
Primary research, market access & HEOR. Proposals within 48 hours.
BioNixus market research
Commission custom Morocco fieldwork
Book a 30-minute briefing to align on DMP pathway intelligence, stakeholder mapping, and competitive tracking for Morocco.
List of Pharmaceutical Companies in Morocco by Category
Morocco pharmaceutical companies span local manufacturers, multinational corporation offices, regional suppliers, and key distributors.
Local Manufacturers
Around 50 licensed plants — led by Sothema, Cooper Pharma, Laprophan, Pharma 5, and Galenica — cover ~70% of domestic volume and increasingly export to Francophone West Africa.
- ✓ Sothema
- ✓ Cooper Pharma
- ✓ Laprophan
- ✓ Pharma 5
- ✓ Galenica
- ✓ Afric-Phar
- ✓ Zenith Pharma
Multinational Offices
Multinationals combine Casablanca scientific offices with local manufacturing partnerships; Sanofi's Maphar heritage gives it the deepest local footprint.
- ✓ Sanofi Maroc (Maphar)
- ✓ Pfizer
- ✓ Novartis
- ✓ Roche
- ✓ GSK
- ✓ AstraZeneca
- ✓ MSD
Regional Players
MENA players such as Hikma and Julphar compete in hospital injectables and retail generics.
- ✓ Hikma Pharmaceuticals
- ✓ Julphar
Distributors
A consolidated wholesale layer (Maphar Distribution, Sophadial, and regional grossisteries) serves roughly 12,000 pharmacies.
- ✓ Maphar Distribution
- ✓ Sophadial / regional wholesalers
Pharmaceutical Companies in Morocco: DMP Regulatory Landscape
Direction du Médicament et de la Pharmacie (Ministry of Health) is Morocco's pharmaceutical regulator.
Regulatory Authority
Direction du Médicament et de la Pharmacie (Ministry of Health) (DMP) oversees registration, quality control, pricing, vigilance, and import licensing.
Registration Timeline
12–24 months
Renewal Period
5 years
Pricing Model
Government-decreed price ceilings referenced to a 6-country external basket (incl. France, Spain, Turkey, Saudi Arabia)
Key Registration Requirements
- ✓CTD dossier in French via DMP
- ✓GMP certificate; site inspection possible
- ✓Certificate of Pharmaceutical Product (CPP)
- ✓French/Arabic labelling
- ✓Local pharmaceutical establishment (établissement pharmaceutique) required
- ✓Price approval by decree before marketing
Market Access Note
AMO generalisation is extending mandatory health insurance to the full population, expanding reimbursed drug demand through CNSS/CNOPS channels. Public procurement runs through Ministry of Health tenders; the private channel remains the value majority.
Morocco Pharmaceutical Market Growth Drivers
AMO Universal Insurance
The AMO generalisation programme is bringing millions of newly insured patients into reimbursed pharmaceutical demand.
Local Manufacturing Policy
Government policy favours local production and positions Morocco as a vaccine and biosimilar manufacturing hub for Africa.
Francophone Africa Exports
Moroccan manufacturers use shared language, banking, and logistics ties to grow exports across West Africa.
Oncology & Specialty Growth
Cancer centre expansion (Institut National d'Oncologie network) drives innovative oncology uptake.
Vaccine Sovereignty Projects
The SENSYO Pharmatech project targets large-scale vaccine and biologic fill-finish capacity near Casablanca.
Medical Infrastructure Investment
New CHU university hospitals in Tangier, Agadir, and Laâyoune expand tertiary pharmaceutical demand.
How BioNixus Supports Pharmaceutical Companies in Morocco
BioNixus is a healthcare market research company with primary-research capability in Morocco and cross-market benchmarking against GCC, USA, and European markets. We help pharma, biotech, and medtech companies with:
Physician Surveys & KOL Mapping
French-Arabic fieldwork with Moroccan physicians across CHU, military, and private clinics.
Market Access & DMP Strategy
DMP registration pathway analysis, price-decree benchmarking, and AMO reimbursement intelligence.
Competitive Intelligence
Tracking launches, MOH tender awards, and local manufacturer pipelines across the Maghreb.
Maghreb & Africa Benchmarking
Comparative entry analysis across Morocco, Algeria, Tunisia, Egypt, and Francophone West Africa.
Frequently Asked Questions
How many pharmaceutical companies operate in Morocco?
Morocco has around 50 licensed pharmaceutical manufacturing sites and 40+ importers. Leaders include Sothema, Cooper Pharma, Laprophan, Pharma 5, and Galenica among locals, with Sanofi (Maphar), Pfizer, Novartis, Roche, GSK, AstraZeneca, and MSD among multinationals.
What is the size of Morocco's pharmaceutical market?
Morocco's pharmaceutical market is valued at approximately US$2–2.5 billion in 2026, growing ~6–7% annually — North Africa's second-largest market after Egypt. Local production covers about 70% of volume.
Who regulates pharmaceuticals in Morocco?
The Direction du Médicament et de la Pharmacie (DMP) within the Ministry of Health handles registration, pricing, quality control, and pharmacovigilance. Registration takes 12–24 months and requires a local pharmaceutical establishment.
How does drug pricing work in Morocco?
Prices are set by government decree using external reference pricing against a six-country basket including France, Spain, Turkey, and Saudi Arabia. The 2014 pricing reform cut prices significantly and the framework has been periodically revised since.
What is AMO and why does it matter for pharma?
AMO (Assurance Maladie Obligatoire) is Morocco's mandatory health insurance, now being generalised to the entire population including the former RAMED (public assistance) beneficiaries. It expands reimbursed pharmaceutical demand through CNSS and CNOPS payer channels — the market's biggest structural growth driver.
Can Morocco serve as an Africa export base?
Yes. Moroccan manufacturers export across Francophone West Africa, supported by banking, logistics, and free-trade links. Government-backed projects such as SENSYO Pharmatech aim to make Morocco a vaccine and biologics manufacturing hub for the continent.
Data Sources & Methodology
This guide aggregates publicly available information from:
- DMP — Direction du Médicament et de la Pharmacie (Ministère de la Santé)
- Les Industriels du Médicament au Maroc (LEMM) publications
- AMO/CNSS coverage statistics
- Company filings (Casablanca Stock Exchange)
- BioNixus proprietary research (Maghreb & MENA, 2024–2026)
Company lists are editorial snapshots, not endorsements; market sizes are BioNixus estimate ranges synthesised from regulator and industry sources. For customised market intelligence on Morocco, contact our team.